ReCLAIM-2 Study to Evaluate Safety,Efficacy & Pharmacokinetics of Elamipretide in Subjects With AMD With Non-central GA

Clinical trial NCT03891875 · COMPLETED

Trial details

NCT number: NCT03891875
Sponsor: Stealth BioTherapeutics Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Age-related Macular Degeneration

Start date: 2019-03-27
Primary completion: 2022-02-22
Enrollment: 176

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.